London-based health-care company BTG has agreed to buy medical-device maker Ekos of Bothell for $180 million or more, the companies said Friday.
Ekos developed an ultrasound-enhanced system for breaking up blood clots, marketed since 2006 and now used in 490 U.S. hospitals and another 100 elsewhere.
It had $28 million in revenue last year and a $ 2 million operating profit, compared with $20 million in sales and a $1 million loss the year before, according to a BTG statement.
The company’s 150 employees are expected to remain with BTG, the statement said.
- More pet-food recalls linked to potential salmonella contamination
- Seattle company copes with backlash on $70,000 minimum wage
- Man drowns in Lake Washington after hopping off boat
- Impressions from day 3 of Seahawks training camp --- Christine Michael, the center position, Tyler Lockett, and more
- After signing $43 million contract, Bobby Wagner admits he didn’t expect Seattle to draft him
Most Read Stories
In addition to the $180 million purchase price, the deal has provisions for up to $40 million in future milestone payments.